title: Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?
authors.forename: S
authors.initials: S
authors.lastname: Chunduri
authors.forename: L C
authors.initials: LC
authors.lastname: Dobogai
authors.forename: A
authors.initials: A
authors.lastname: Bruno
authors.forename: S
authors.initials: S
authors.lastname: Kadkol
authors.forename: D
authors.initials: D
authors.lastname: Rondelli
mesh_terms: D001549:Benzamides; D006086:Graft vs Host Disease / Q000188:drug therapy*; D020544:Graft vs Leukemia Effect / Q000187:drug effects*; D006801:Humans; D000068877:Imatinib Mesylate; D036102:Peripheral Blood Stem Cell Transplantation; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate